{"count": 36, "results": [{"_id": "36551216", "pmid": 36551216, "pmcid": "PMC9775246", "title": "Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet", "journal": "Biomolecules", "authors": ["Baiges-Gaya G", "Rodríguez-Tomàs E", "Castañé H", "Jiménez-Franco A", "Amigó N", "Camps J", "Joven J"], "date": "2022-11-30T00:00:00Z", "doi": "10.3390/biom12121787", "meta_date_publication": "2022 Nov 30", "meta_volume": "12", "meta_issue": "12", "meta_pages": "", "score": 50277.6, "text_hl": "Combining Dietary Intervention with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment Enhances @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@Non-Alcoholic Steatohepatitis@@@ Remission in @SPECIES_10090 @@@Mice@@@ Fed a High-Fat High-@CHEMICAL_Sucrose @CHEMICAL_MESH:D013395 @@@Sucrose@@@ Diet", "citations": {"NLM": "Baiges-Gaya G, Rodríguez-Tomàs E, Castañé H, Jiménez-Franco A, Amigó N, Camps J, Joven J. Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet Biomolecules. 2022 Nov 30;12(12):. PMID: 36551216", "BibTeX": "@article{36551216, title={Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet}, author={Baiges-Gaya G and Rodríguez-Tomàs E and Castañé H and Jiménez-Franco A and Amigó N and Camps J and Joven J}, journal={Biomolecules}, volume={12}, number={12}}"}}, {"_id": "37652508", "pmid": 37652508, "title": "Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.", "journal": "In Vivo", "authors": ["Chen D", "Xiong J", "Chen G", "Zhang Z", "Liu Y", "Xu J", "Xu H"], "date": "2023-09-01T00:00:00Z", "doi": "10.21873/invivo.13308", "meta_date_publication": "2023 Sep-Oct", "meta_volume": "37", "meta_issue": "5", "meta_pages": "2105-2127", "score": 50268.36, "text_hl": "Model rats were fed high-fat diets to create @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@ models. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ or @CHEMICAL_Berberine @CHEMICAL_MESH:D001599 @@@BER@@@ rats were administrated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ or @CHEMICAL_Berberine @CHEMICAL_MESH:D001599 @@@BER@@@, respectively, at the onset of induction of @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@. ", "citations": {"NLM": "Chen D, Xiong J, Chen G, Zhang Z, Liu Y, Xu J, Xu H. Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis. In Vivo. 2023 Sep-Oct;37(5):2105-2127. PMID: 37652508", "BibTeX": "@article{37652508, title={Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.}, author={Chen D and Xiong J and Chen G and Zhang Z and Liu Y and Xu J and Xu H}, journal={In Vivo}, volume={37}, number={5}, pages={2105-2127}}"}}, {"_id": "37103096", "pmid": 37103096, "title": "Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis.", "journal": "In Vivo", "authors": ["Chiu HY", "Tsai SC", "Tsai FJ", "Lo YH", "Cheng CC", "Liu TY", "Jhan SR", "Yang JS", "Chiu YJ"], "date": "2023-05-01T00:00:00Z", "doi": "10.21873/invivo.13178", "meta_date_publication": "2023 May-Jun", "meta_volume": "37", "meta_issue": "3", "meta_pages": "1037-1046", "score": 50266.207, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and liraglutide have both benefited @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@ treatment. ", "citations": {"NLM": "Chiu HY, Tsai SC, Tsai FJ, Lo YH, Cheng CC, Liu TY, Jhan SR, Yang JS, Chiu YJ. Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis. In Vivo. 2023 May-Jun;37(3):1037-1046. PMID: 37103096", "BibTeX": "@article{37103096, title={Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis.}, author={Chiu HY and Tsai SC and Tsai FJ and Lo YH and Cheng CC and Liu TY and Jhan SR and Yang JS and Chiu YJ}, journal={In Vivo}, volume={37}, number={3}, pages={1037-1046}}"}}, {"_id": "32758573", "pmid": 32758573, "title": "Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.", "journal": "Eur J Pharmacol", "authors": ["Ahmed LA", "Salem MB", "Seif El-Din SH", "El-Lakkany NM", "Ahmed HO", "Nasr SM", "Hammam OA", "Botros SS", "Saleh S"], "date": "2020-11-15T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173461", "meta_date_publication": "2020 Nov 15", "meta_volume": "887", "meta_issue": "", "meta_pages": "173461", "score": 50262.1, "text_hl": "Gut microbiota modulation as a promising therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@non-alcoholic steatohepatitis@@@: Role of @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@/@GENE_TLR4 @GENE_29260 @@@TLR4@@@ and autophagy pathways.", "citations": {"NLM": "Ahmed LA, Salem MB, Seif El-Din SH, El-Lakkany NM, Ahmed HO, Nasr SM, Hammam OA, Botros SS, Saleh S. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways. Eur J Pharmacol. 2020 Nov 15;887():173461. PMID: 32758573", "BibTeX": "@article{32758573, title={Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.}, author={Ahmed LA and Salem MB and Seif El-Din SH and El-Lakkany NM and Ahmed HO and Nasr SM and Hammam OA and Botros SS and Saleh S}, journal={Eur J Pharmacol}, volume={887}, pages={173461}}"}}, {"_id": "34977520", "pmid": 34977520, "pmcid": "PMC8686034", "title": "Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions", "journal": "JHEP Rep", "authors": ["Anstee QM", "Hallsworth K", "Lynch N", "Hauvespre A", "Mansour E", "Kozma S", "Marino JP", "Bottomley J", "Piercy J", "Higgins V"], "date": "2021-11-22T00:00:00Z", "doi": "10.1016/j.jhepr.2021.100411", "meta_date_publication": "2022 Jan", "meta_volume": "4", "meta_issue": "1", "meta_pages": "100411", "score": 50252.36, "text_hl": "Two-thirds of @SPECIES_9606 @@@patients@@@ were receiving off-label treatment for @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@ or associated underlying conditions with the aim of improving @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@, most commonly statins, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Vitamin_E @CHEMICAL_MESH:D014810 @@@vitamin E", "citations": {"NLM": "Anstee QM, Hallsworth K, Lynch N, Hauvespre A, Mansour E, Kozma S, Marino JP, Bottomley J, Piercy J, Higgins V. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions JHEP Rep. 2022 Jan;4(1):100411. PMID: 34977520", "BibTeX": "@article{34977520, title={Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions}, author={Anstee QM and Hallsworth K and Lynch N and Hauvespre A and Mansour E and Kozma S and Marino JP and Bottomley J and Piercy J and Higgins V}, journal={JHEP Rep}, volume={4}, number={1}, pages={100411}}"}}, {"_id": "32278041", "pmid": 32278041, "title": "The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.", "journal": "Pharmacol Res", "authors": ["Jalali M", "Rahimlou M", "Mahmoodi M", "Moosavian SP", "Symonds ME", "Jalali R", "Zare M", "Imanieh MH", "Stasi C"], "date": "2020-09-01T00:00:00Z", "doi": "10.1016/j.phrs.2020.104799", "meta_date_publication": "2020 Sep", "meta_volume": "159", "meta_issue": "", "meta_pages": "104799", "score": 50252.027, "text_hl": "The effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration on liver enzymes and body composition in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver disease@@@ and/or @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@non-alcoholic steatohepatitis@@@: An up-to date systematic review and meta-analysis of randomized controlled trials.", "citations": {"NLM": "Jalali M, Rahimlou M, Mahmoodi M, Moosavian SP, Symonds ME, Jalali R, Zare M, Imanieh MH, Stasi C. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020 Sep;159():104799. PMID: 32278041", "BibTeX": "@article{32278041, title={The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.}, author={Jalali M and Rahimlou M and Mahmoodi M and Moosavian SP and Symonds ME and Jalali R and Zare M and Imanieh MH and Stasi C}, journal={Pharmacol Res}, volume={159}, pages={104799}}"}}, {"_id": "35991764", "pmid": 35991764, "title": "A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians.", "journal": "Can Liver J", "authors": ["Sebastiani G", "Ramji A", "Swain MG", "Patel K"], "date": "2021-04-29T00:00:00Z", "doi": "10.3138/canlivj-2020-0033", "meta_date_publication": "2021 Spring", "meta_volume": "4", "meta_issue": "2", "meta_pages": "82-92", "score": 50248.105, "text_hl": "Finally, more than 40% of PCPs, 22% of specialists, and 33% of nurses thought that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and statin were treatments for @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@NASH@@@. ", "citations": {"NLM": "Sebastiani G, Ramji A, Swain MG, Patel K. A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians. Can Liver J. 2021 Spring;4(2):82-92. PMID: 35991764", "BibTeX": "@article{35991764, title={A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians.}, author={Sebastiani G and Ramji A and Swain MG and Patel K}, journal={Can Liver J}, volume={4}, number={2}, pages={82-92}}"}}, {"_id": "11567710", "pmid": 11567710, "title": "Metformin in non-alcoholic steatohepatitis.", "journal": "Lancet", "authors": ["Marchesini G", "Brizi M", "Bianchi G", "Tomassetti S", "Zoli M", "Melchionda N"], "date": "2001-09-15T00:00:00Z", "doi": "10.1016/s0140-6736(01)06042-1", "meta_date_publication": "2001 Sep 15", "meta_volume": "358", "meta_issue": "9285", "meta_pages": "893-4", "score": 50090.785, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@non-alcoholic steatohepatitis@@@.", "citations": {"NLM": "Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 2001 Sep 15;358(9285):893-4. PMID: 11567710", "BibTeX": "@article{11567710, title={Metformin in non-alcoholic steatohepatitis.}, author={Marchesini G and Brizi M and Bianchi G and Tomassetti S and Zoli M and Melchionda N}, journal={Lancet}, volume={358}, number={9285}, pages={893-4}}"}}, {"_id": "11830232", "pmid": 11830232, "title": "Metformin in non-alcoholic steatohepatitis.", "journal": "Lancet", "authors": ["Urso R", "Visco-Comandini U"], "date": "2002-01-26T00:00:00Z", "doi": "10.1016/S0140-6736(02)07566-9", "meta_date_publication": "2002 Jan 26", "meta_volume": "359", "meta_issue": "9303", "meta_pages": "355-6", "score": 50090.6, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@non-alcoholic steatohepatitis@@@.", "citations": {"NLM": "Urso R, Visco-Comandini U. Metformin in non-alcoholic steatohepatitis. Lancet. 2002 Jan 26;359(9303):355-6. PMID: 11830232", "BibTeX": "@article{11830232, title={Metformin in non-alcoholic steatohepatitis.}, author={Urso R and Visco-Comandini U}, journal={Lancet}, volume={359}, number={9303}, pages={355-6}}"}}, {"_id": "14987322", "pmid": 14987322, "title": "Metformin in the treatment of patients with non-alcoholic steatohepatitis.", "journal": "Aliment Pharmacol Ther", "authors": ["Uygun A", "Kadayifci A", "Isik AT", "Ozgurtas T", "Deveci S", "Tuzun A", "Yesilova Z", "Gulsen M", "Dagalp K"], "date": "2004-03-01T00:00:00Z", "doi": "10.1111/j.1365-2036.2004.01888.x", "meta_date_publication": "2004 Mar 1", "meta_volume": "19", "meta_issue": "5", "meta_pages": "537-44", "score": 50081.355, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Fatty_Liver_Alcoholic</m> @DISEASE_MESH:D005235 @@@non-alcoholic steatohepatitis@@@.", "citations": {"NLM": "Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, Yesilova Z, Gulsen M, Dagalp K. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2004 Mar 1;19(5):537-44. PMID: 14987322", "BibTeX": "@article{14987322, title={Metformin in the treatment of patients with non-alcoholic steatohepatitis.}, author={Uygun A and Kadayifci A and Isik AT and Ozgurtas T and Deveci S and Tuzun A and Yesilova Z and Gulsen M and Dagalp K}, journal={Aliment Pharmacol Ther}, volume={19}, number={5}, pages={537-44}}"}}]}